Generative AI imagines new protein structures
“FrameDiff” is a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.
Novo Nordisk to support MIT postdocs working at the intersection of AI and life sciences
MIT-Novo Nordisk Artificial Intelligence Postdoctoral Fellows Program will support up to 10 postdocs annually over five years.
From molecular to whole-brain scale in a simple animal, study reveals serotonin’s effects
With full genetic control and visibility into neural activity and behavior, MIT scientists map out chemical’s role in behavior.
Researchers develop novel AI-based estimator for manufacturing medicine
A collaborative research team from the MIT-Takeda Program combined physics and machine learning to characterize rough particle surfaces in pharmaceutical pills and powders.
Speeding up drug discovery with diffusion generative models
MIT researchers built DiffDock, a model that may one day be able to find new drugs faster than traditional methods and reduce the potential for adverse side effects.
MIT-Takeda Program heads into fourth year with crop of 10 new projects
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.
Startups led by MIT mechanical engineers offer health care solutions
Companies founded by MechE faculty and alumni solve a variety of health care challenges, from better drug delivery to robotic surgery.
Professor Emeritus Richard Wurtman, influential figure in translational research, dies at 86
Longtime MIT professor of neuroscience led research behind 200 patents, laying the groundwork for numerous medical products.
The economics of missed opportunities
Danielle Li takes a close look at scientific practices and organizational decisions — and provides data about improving them.
Artificial intelligence model finds potential drug molecules a thousand times faster
A geometric deep-learning model is faster and more accurate than state-of-the-art computational models, reducing the chances and costs of drug trial failures.
New light-powered catalysts could aid in manufacturing
When coated onto plastic tubing, the catalysts could act on chemicals flowing through, helping to synthesize drugs and other compounds.
Can artificial intelligence overcome the challenges of the health care system?
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
A smarter way to develop new drugs
A new artificial intelligence technique only proposes candidate molecules that can actually be produced in a lab.
Reversing hearing loss with regenerative therapy
MIT spinout Frequency Therapeutics’ drug candidate stimulates the growth of hair cells in the inner ear.
From bench to biotech
Life sciences class brings biotech industry experience into the classroom with part-time internships for graduate students.